PUNJABCHEMPunjab Chemicals & Crop Protection Limited
Convert to ideaChemicals & Petrochemicals · Agrochemicals
The verdict combines business quality, price and timing. Sign in free to see it.
Sign in freeDown 2.2 this quarter.
Momentum from moving averages, Supertrend and RSI.
8 forensic issues found. Sign in to see which.
Valuation Metrics
Q2 FY2027Intrinsic value, Graham number and DCF against today's price
8 found · risk severe
Quality, growth, balance sheet and earnings quality behind the score
ⓘ Based on fundamental & forensic analysis. Always verify against official filings and consult a financial advisor.
Financial Metrics
Comparing Q2 FY2027 vs Q2 FY2026
| Quarter | Revenue | Net Profit | OPM | NPM | EPS | Int. Cover |
|---|---|---|---|---|---|---|
| Q2 FY2027 | ₹327 Cr | ₹13 Cr | 6.60% | 4.12% | ₹10.98 | 4.2x |
| Q1 FY2027 | ₹347 Cr | ₹22 Cr | 9.64% | 6.36% | ₹18.00 | 8.3x |
| Q4 FY2026 | ₹209 Cr | ₹11 Cr | 9.02% | 5.26% | ₹8.96 | 4.2x |
| Q3 FY2026 | ₹247 Cr | ₹14 Cr | 9.23% | 5.60% | ₹11.26 | 5.6x |
| Q2 FY2026 | ₹255 Cr | ₹19 Cr | 7.68% | 7.27% | ₹15.12 | 6.8x |
| Q1 FY2026 | ₹320 Cr | ₹21 Cr | 8.72% | 6.46% | ₹16.83 | 8.0x |
Momentum score, 1-year chart, moving averages, support and resistance.
Turnaround stage, and how each measure moved over 3 years against the company's own range.
Order wins, capex, pledges, rating actions and every material filing.
Management guidance, Q&A highlights and whether they delivered what they said.
The earnings call read across investor dimensions.
Promoter, FII and mutual fund holding, and what changed this quarter.
Similar-size peers in Agrochemicals
Compare with peers →Punjab Chemicals and Crop Protection Limited manufactures and sells agrochemicals, specialty chemicals, bulk drugs, and related intermediates in India, Europe, Japan, Israel, the United States, Latin America, and internationally. It offers herbicides, including metamitron, ethofumesate, diflufenican, lenacil, and cyanazine; insecticides and fungicides; pharma active pharmaceutical ingredients (API) comprising trimethoprim IP/BP/USP/EP, etoricoxib, celecoxib, albendazole USP/BP/IP, drotaverine HCL; and pharma intermediates, advance intermediates for API, and antioxidants. The company provides fine and specialty chemicals; basic and industrial chemicals, such as oxalates and intermediates; and phosphorus derivatives and phosphates. In addition, it is involved in international trading of chemicals; and provision of research and development and contract manufacturing services. The company was incorporated in 1975 and is based in Mumbai, India.
Note: This comprehensive analysis combines technical data, fundamental data, and investment thesis. Always do your own research and consider your personal risk tolerance before investing.